11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Picosecond Nd:YAG Laser (PICOCAREMAJESTY)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

"2.0/2.4MM" FRACTURE SYSTEM

FDA UDI
BIOMET MICROFIXATION, INC·00841036036171·

STA LIATEST D-DI

FDA 510(k)
FDA Class 2 ·Hematology

RANDOX OPIATES ASSAY

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·August 29, 2025

AMPLATZER PFO OCCLUDER

FDA Adverse Event
Injury ·AGA MEDICAL CORPORATION·Product code MLV·March 10, 2020

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM VG NON US

FDA Adverse Event
Injury ·COSTA RICA·Product code LTI·November 19, 2008

9900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·August 17, 2011

HEARTMATE II LVAS

FDA Adverse Event
THORATEC CORPORATION·Product code DSQ·July 22, 2013

LIBERTY CYCLER SET, SINGLE CONN./EXT. DL

FDA Adverse Event
Malfunction ·REYNOSE MANUFACTURING·Product code FKX·August 19, 2011

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014